CN Patent

CN111343983A — 使用ccr3抑制剂治疗瘙痒、干燥症和相关疾病的方法和组合物

Assigned to Alkahest Inc · Expires 2020-06-26 · 6y expired

What this patent protects

提供了用CCR3调节剂治疗皮肤病症的症状的方法。所述方法包括向受试者施用治疗有效量的CCR3调节剂，同时改善瘙痒、干燥症或其他皮肤病症影响的功能。本发明的方法可改善其症状和病因的皮肤病症包括湿疹、大疱性类天疱疮、特应性皮炎和银屑病。

USPTO Abstract

提供了用CCR3调节剂治疗皮肤病症的症状的方法。所述方法包括向受试者施用治疗有效量的CCR3调节剂，同时改善瘙痒、干燥症或其他皮肤病症影响的功能。本发明的方法可改善其症状和病因的皮肤病症包括湿疹、大疱性类天疱疮、特应性皮炎和银屑病。

Drugs covered by this patent

Patent Metadata

Patent number
CN111343983A
Jurisdiction
CN
Classification
—
Expires
2020-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Alkahest Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.